Oncology Data Advisor
U

Can Diet and Nutrition Impact Multiple Myeloma Outcomes?

By Oncology Data Advisor FEATURING Urvi Shah, Rahul Banerjee
April 27, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

06:53
Sanofi

Geographic and Socioeconomic Disparities in HCT Access for MM: Impac…

Feat. L. Costa

Featured Video

06:56
Sanofi

Autologous HCT in Older Adults with MM: Eligibility Assessment

Feat. T. Wildes

Related Content

AUTOPLAY
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
06:56
Sanofi

Autologous HCT in Older Adults with MM: Eligibility Assessment

Feat. T. Wildes
06:53
Sanofi

Geographic and Socioeconomic Disparities in HCT Access for MM: Impac…

Feat. L. Costa
12:14
2021 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Recommendations on the Use of Clinically-Assisted Nutrition in Patie…

Feat. B. Alderman
18:14
Eighth Annual Scripps Cancer Care Symposium

Malnutrition Management in Cancer for Nurses: Which Factors Contribu…

Feat. M. Petzel
24:19
Dana-Farber Cancer Institute

Phase 3 DETERMINATION Trial: RVd ± ASCT & Lenalidomide Maintenan…

Feat. P. Richardson
14:34
Houston Methodist Hospital

Nutrition and Cancer: Why It Matters

Feat. R. Stubbins
10:29
Mary Kwok

Moving to Quadruplets in NDMM

31:36
Nebraska Oncology Society

ASCO 2022 on Moving Toward a Cure in Myeloma: The Role of MRD Testing

Feat. A. Nooka
13:08
University of Virginia School of Medicine and School of Nursing

Culinary Medicine for Cancer Prevention: Why Is Culinary Medicine Im…

Feat. T. Petzold
16:18
Physicians Committee for Responsible Medicine

What Are the Causes of Hypothyroidism and Hyperthyroidism? Are Dieta…

Feat. N. Barnard
34:28
2022 Community Oncology Conference

Treatment Conundrums in Myeloma

Feat. S. Giralt
12:07
SIO 16th International Conference in Integrative Oncology

Applying Intermittent Fasting or Caloric Restriction in Clinical Pra…

Feat. C. Lourie
17:59
Parameswaran Hari

Delivering the Best Initial Treatment for Myeloma: Induction Therapy…

33:28
Cleveland Clinic Taussig Cancer Institute

Management of Relapsed/Refractory Multiple Myeloma

Feat. F. Anwer
15:12
Yale Cancer Center

ASH 2021: Cellular Therapies in Myeloma

Feat. N. Bar
10:40
Claudio Cerchione

Frontline MM State of the Art: Can We Prolong PFS With D-VTd in ASCT…

26:05
SOHO Italy 1st School of Multiple Myeloma

Introducing Anti-CD38 in Daily Practice of MM: Updates on the GRIFFI…

Feat. C. Cerchione
16:57
SOHO Italy 1st School of Multiple Myeloma

Anti-CD38 in MM Daily Practice: How Can We Potentiate the Action of …

Feat. C. Cerchione
15:57
SOHO 3rd Italian Conference

SOHO Italy 2021 on CAR T in MM: Preliminary Data and Perspectives

Feat. C. Cerchione